CN202191344U - Medical magnesium alloy implant capable of delaying degradation - Google Patents
Medical magnesium alloy implant capable of delaying degradation Download PDFInfo
- Publication number
- CN202191344U CN202191344U CN2011203021995U CN201120302199U CN202191344U CN 202191344 U CN202191344 U CN 202191344U CN 2011203021995 U CN2011203021995 U CN 2011203021995U CN 201120302199 U CN201120302199 U CN 201120302199U CN 202191344 U CN202191344 U CN 202191344U
- Authority
- CN
- China
- Prior art keywords
- magnesium alloy
- human body
- medical
- alloy implant
- degradation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
The utility model relates to the technical field of medical implanting materials, in particular to a medical magnesium alloy implant capable of delaying degradation, which is provided with a magnesium alloy implant body; and one layer of material membrane which contains elements beneficial to a human body is formed on the magnesium alloy implant body through plasma spraying, and the beneficial elements are necessary for the human body daily, such as ferrum, calcium and the like. By adopting the structure, the layer of thin material membrane is sprayed through the plasma spraying technology, so that a certain protection role on the medical magnesium alloy body can be played, and the degradation of the magnesium alloy body can be delayed, thus playing a long-term supporting role; and the elements such as the ferrum, the calcium and the like in the material membrane can be absorbed by the human body for daily requirements of the human body, and simultaneously a caring role can be played on relevant organics of the human body.
Description
Technical field:
This utility model relates to the medical embedded material technical field, refers in particular to a kind of magnesium alloy medical implant that delays to degrade.
Background technology:
The main magnesium alloy materials that adopts such as degradable medical implant such as nail, hone lamella etc. is made.Existing magnesium alloy medical embedded object; Only have an object body of being made by magnesium alloy, the surface does not have other materials again, like this behind implant into body; Magnesium alloy directly contacts with human body fluid; Degradation speed is very fast, therefore embedded object might take place do not accomplish the phenomenon that the implantation mission is promptly degraded and finished, the healing deleterious impact of giving conditions of patients.
The utility model content:
The purpose of this utility model is to overcome the above-mentioned weak point of existing medical implant, and a kind of magnesium alloy medical implant that delays to degrade is provided.
This utility model realizes that the technical scheme that its purpose adopts is: a kind of magnesium alloy medical implant that delays to degrade; It has a magnesium alloy implant body, forms one deck in said this external surface of magnesium alloy implant sputter and contains the material film to human body beneficial's element.
Described element to the human body beneficial can be human body necessary elements every day such as ferrum, calcium.
After this utility model adopts said structure; Technology through plasma sputtering is sprayed the very thin material film of one deck; Not only can form the certain protection effect, delay the degraded of magnesium alloy articles, thereby play a long-term effect of supporting the magnesium alloy articles body in it; And, but elements such as the ferrum of human body assimilate plasma membrane the inside, calcium supply the human body daily need, also can play the effect of a maintenance treatment simultaneously to the relevant organ of human body.
Description of drawings:
Fig. 1 is the structural representation of the medical embedded object of a kind of embodiment of this utility model;
The specific embodiment:
Below in conjunction with specific embodiment and accompanying drawing this utility model is further specified.
As shown in Figure 1; A kind of magnesium alloy medical implant that delays to degrade; Have a magnesium alloy implant body 1, present embodiment is an example with the magnesium alloy nail, forms layer of substance film 2 at this magnesium alloy implant body 1 outer surface; Contain the element to the human body beneficial such as ferrum, calcium in this material film 2, material film 2 is that the technology with plasma sputtering is formed on the nail outer surface.
After this utility model adopted said structure, material film 2 not only can form the certain protection effect to the magnesium alloy articles body in it 1, delays the degraded of magnesium alloy articles, thereby played a long-term effect of supporting; And elements such as the ferrum of human body absorbable metal material film the inside, calcium supply the human body daily need, also can play the effect of a maintenance treatment simultaneously to the relevant organ of human body.
The above is a simple embodiment of this utility model, and the protection domain of non-limiting this utility model; The kind of magnesium alloy medical embedded object is varied, differs at this and one enumerates, and on various magnesium alloy medical embedded objects, all can spray the respective substance film.
Claims (1)
1. magnesium alloy medical implant that can delay to degrade, it has a magnesium alloy implant body (1), it is characterized in that: form one deck in said magnesium alloy implant body (1) outer surface sputter and contain the material film (2) to human body beneficial's element.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011203021995U CN202191344U (en) | 2011-08-18 | 2011-08-18 | Medical magnesium alloy implant capable of delaying degradation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011203021995U CN202191344U (en) | 2011-08-18 | 2011-08-18 | Medical magnesium alloy implant capable of delaying degradation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202191344U true CN202191344U (en) | 2012-04-18 |
Family
ID=45946277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011203021995U Expired - Fee Related CN202191344U (en) | 2011-08-18 | 2011-08-18 | Medical magnesium alloy implant capable of delaying degradation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202191344U (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103182100A (en) * | 2013-03-14 | 2013-07-03 | 东莞宜安科技股份有限公司 | Medical degradable magnesium alloy material with iron ion membrane sputtered on surface and preparation process |
| CN104491935A (en) * | 2014-12-30 | 2015-04-08 | 马艳荣 | Drug-loading magnesium alloy eluting stent for biodegradable polymer coating |
| CN104587537A (en) * | 2014-12-30 | 2015-05-06 | 马艳荣 | Magnesium alloy eluting stent with biodegradable polymer coatings carrying drugs |
| CN112315536A (en) * | 2020-11-24 | 2021-02-05 | 四川大学 | Heart occlusion device and preparation method thereof |
-
2011
- 2011-08-18 CN CN2011203021995U patent/CN202191344U/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103182100A (en) * | 2013-03-14 | 2013-07-03 | 东莞宜安科技股份有限公司 | Medical degradable magnesium alloy material with iron ion membrane sputtered on surface and preparation process |
| CN104491935A (en) * | 2014-12-30 | 2015-04-08 | 马艳荣 | Drug-loading magnesium alloy eluting stent for biodegradable polymer coating |
| CN104587537A (en) * | 2014-12-30 | 2015-05-06 | 马艳荣 | Magnesium alloy eluting stent with biodegradable polymer coatings carrying drugs |
| CN112315536A (en) * | 2020-11-24 | 2021-02-05 | 四川大学 | Heart occlusion device and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN202191344U (en) | Medical magnesium alloy implant capable of delaying degradation | |
| WO2010121187A3 (en) | Stents having controlled elution | |
| NZ588549A (en) | Stents having bioabsorbable layers | |
| WO2006127079A3 (en) | A coated delivery system for active components as part of an edible composition | |
| DE602008003832D1 (en) | Ystem | |
| WO2011159723A3 (en) | X-ray target and method of making the same | |
| WO2012034079A3 (en) | Macrolide dosage forms | |
| WO2006127070A3 (en) | An edible composition including a delivery system for active components | |
| WO2010021757A3 (en) | Implantable medical device coatings with biodegradable elastomer and releasable taxane agent | |
| WO2006127069A3 (en) | A delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component | |
| WO2009120361A3 (en) | Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery | |
| NZ607498A (en) | Biomaterials with enhanced properties and devices made therefrom | |
| WO2010102254A3 (en) | Thin film vascular stent and biocompatible surface treatment | |
| ATE522195T1 (en) | ABSORPTION ARTICLE WITH BREATHABLE STRETCH COATING | |
| WO2008051265A3 (en) | Engineered cell growth on polymeric films and biotechnological applications there of | |
| NZ622566A (en) | Chromobacterium bioactive compositions and metabolites | |
| WO2007127795A3 (en) | Chitosan/nanocrystalline hydroxyapatite composite microsphere-based scaffolds | |
| WO2012168768A3 (en) | Article with health-benefit agent delivery system | |
| PL1513563T3 (en) | Implant having a long-term antibiotic effect | |
| ES2721475T3 (en) | Implant coated with low crystallization hydroxyapatite in the form of a net or in the form of an island and method of coating the same | |
| WO2009106502A3 (en) | Implant and method for the manufacture thereof | |
| WO2010057949A3 (en) | Methods and systems of controlled coating of nanoparticles onto micro-rough implant surfaces and associated implants | |
| WO2011140416A3 (en) | Medical implants with increased hydrophilicity | |
| WO2010009904A3 (en) | Method for producing a bioactive surface on the balloon of a balloon catheter | |
| WO2011150364A3 (en) | Therapeutic food formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120418 Termination date: 20200818 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |